NTRB Nutriband Inc.
$5.96▼ -0.17%
Healthcare
Other
Volume 503
Avg Volume (10D) 38.7K
Key Metrics & Fundamentals
Market Cap
$72.45M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.80 - 9.19
% vs 50 MA
-2.63%
% vs 200 MA
37.99%
RSI-14
45.9
MACD Histogram
-0.1400
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$584,999
Gross Rev
$181,874
Gross Profit
$181,874
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
GlobeNewswire · Oct 13, 2026 8:00 AM ET
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
GlobeNewswire · Oct 8, 2026 7:00 AM ET
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
GlobeNewswire · Oct 1, 2026 4:05 PM ET
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
GlobeNewswire · Sep 29, 2026 9:25 AM ET
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
GlobeNewswire · Sep 25, 2026 8:00 AM ET
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
GlobeNewswire · Sep 22, 2026 8:00 AM ET
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
GlobeNewswire · Sep 9, 2026 9:20 AM ET
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
GlobeNewswire · Sep 8, 2026 9:00 AM ET
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
GlobeNewswire · Aug 13, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Apr 2026
See NTRB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.